Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT00397397
Other study ID # 15/2006CTIL
Secondary ID
Status Not yet recruiting
Phase Phase 0
First received November 8, 2006
Last updated November 8, 2006
Start date January 2007
Est. completion date March 2007

Study information

Verified date November 2006
Source Hillel Yaffe Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

We wish to determine the best treatment for expulsion of lower ureteral stones. Which of the three major treatment protocols is the best treatment of conservative management of ureteral stones?


Description:

The study will include 60 patients with lower ureteral stones. The patients will be divided into three groups. The first group will be administered Alfuzosin (10 mg). The second group will be administered a combination of Alfuzosin (10 mg)and Rowatinex (Pinene 31%, Camphene 15%, Anetol 4%, Borneol 10%, Cineol 3%, Fenchenol 4%, Olive Oil 33%). The third group will be administered Rowatinex.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date March 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Clinical diagnosis of lower ureter (urinary calculi) up to 8mm

- Must be able to swallow tablets

Exclusion Criteria:

- Sensitivity to Alfuzosin and Rowatinex

- Pregnant and breastfeeding women

- Single kidney

- Obstructing stone

- Renal failure creatinine up to 1.8 mg/dl

- Patients using various alpha blockers

- Liver failure

- Fever higher than 38 C

- UTI

- Syncope or hypotension

- Patients treated with PDE5

- Patients treated with inhibitor CYP3A4

- Patients refusing participation

Study Design

Allocation: Random Sample, Primary Purpose: Screening, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Israel Hillel Yaffe Medical Center Hadera

Sponsors (1)

Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

See also
  Status Clinical Trial Phase
Recruiting NCT04924790 - The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Recruiting NCT05574517 - Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter N/A
Withdrawn NCT00388271 - Use of Alfuzosin in Stone Treatment With ESWL Phase 3
Recruiting NCT02298465 - ESWL for Distal Ureteric Stone: Supine Versus Prone N/A
Active, not recruiting NCT01973088 - Screening and Identification of Human Urate Transporter hURAT1 MicroRNA N/A
Recruiting NCT01884870 - Silent Ureteral Stone: Impact on Renal Function and Kidney Anatomy N/A
Active, not recruiting NCT00575432 - Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy
Completed NCT05027971 - Flexiva Pulse Registry
Terminated NCT00199524 - Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate Phase 4
Recruiting NCT05048706 - SP TLF Versus Ho:YAG Laser N/A
Not yet recruiting NCT04110574 - Computed Tomography Evaluation of Urinary Stones Densities Compared to in Vitro Analysis of Its Chemical Composition
Recruiting NCT02594631 - Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial. Phase 4
Completed NCT00857090 - Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones Phase 1/Phase 2
Completed NCT04112160 - Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal Phase 2
Completed NCT04594161 - Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis N/A
Not yet recruiting NCT04796792 - Ultrasound to Facilitate Stone Passage N/A
Recruiting NCT05270421 - Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi Phase 3
Completed NCT02983409 - Analysis the Relationship Between the Abdomen CT and Outcomes in Acute Urinary Stone Patients N/A
Completed NCT00199459 - Proteomic Study of Urinary Stone Disease N/A